Medication Comparison

Ozempic vs Saxenda

Ozempic (semaglutide) produces more weight loss than Saxenda (liraglutide) with the convenience of weekly dosing, even though Ozempic is technically off-label for obesity. Saxenda has the advantage of being FDA-approved for weight management and approved for teens.

Category Ozempic Saxenda
Brands Ozempic (semaglutide) Saxenda (liraglutide 3mg)
Class GLP-1 RA GLP-1 RA
Administration Weekly injection Daily injection
Average weight loss ~6-10% ~8%
Compounded cost $900-1,100/mo (brand) $1,300-1,500/mo (brand)
Brand cost $900-1,100/mo $1,300-1,500/mo
Half-life ~7 days ~13 hours
Dosing frequency Once weekly Once daily
Key trial SUSTAIN trials SCALE (8% weight loss)

Best for Ozempic

Adults wanting more effective weight loss with weekly convenience

Best for Saxenda

Adolescents or patients who need an FDA-approved weight loss medication specifically

Ozempic tradeoffs

Pros

  • Weekly dosing convenience
  • More effective for weight loss
  • Better A1C reduction

Cons

  • Not approved for weight loss
  • Off-label use for obesity

Saxenda tradeoffs

Pros

  • FDA-approved for weight loss
  • Approved for adolescents 12+
  • Long safety track record

Cons

  • Daily injections required
  • Less effective than semaglutide
  • Higher brand cost

Common questions

Is Ozempic better than Saxenda?

For weight loss, studies show semaglutide (Ozempic's ingredient) achieves roughly twice the weight loss of liraglutide (Saxenda's ingredient). Ozempic also has the advantage of weekly dosing.

Why is Saxenda more expensive than Ozempic?

Saxenda is priced as an obesity medication while Ozempic is a diabetes drug. Insurance coverage varies — many plans cover Ozempic for diabetes but not Saxenda for weight loss.

Can I take Saxenda and Ozempic together?

No, you should not take two GLP-1 receptor agonists simultaneously. Both work on the same receptor, and combining them increases side effect risk without added benefit.

Compare clinics that prescribe these medications

Use provider pages to compare clinical oversight, medication source, and pricing transparency before starting.

View Providers